F. Randy Vogenberg, PhD, FASHP

Principal, Institute for Integrated Healthcare
Board Chair, the Employer–Provider Interface Council (EPIC)
Greenville, SC
Authored Items
Persistent GERD Symptoms Call for Change in Care Management Coverage: A Real-World Perspective for Chronic Care Policy
F. Randy Vogenberg, PhD, FASHP, Murray L. Harber
December 2022 Vol 15, No 4 in Business, Review Article
Global Issues Driving US Healthcare Trends in 2021 and 2022
F. Randy Vogenberg, PhD, FASHP, John Santilli, MBA
Web Exclusives in Industry Trends
Return to Business During a Pandemic: Market Collaboration and Health Benefit Trends
F. Randy Vogenberg, PhD, FASHP
June 2020 Vol 13, No 3 in Industry Trends
Medication Use Before and After Hospitalization for Chronic Obstructive Pulmonary Disease in a Cohort of Elderly Patients with a Medicare Advantage Plan
F. Randy Vogenberg, PhD, FASHP, Qingqing Xu, MS, Sarah S. Laxa, PharmD, Omar Serna, PharmD, BCACP, Sujit S. Sansgiry, MS, PhD
February 2020 Vol 13, No 1 in Clinical, Original Research
Key Trends in Healthcare for 2020 and Beyond
F. Randy Vogenberg, PhD, FASHP, John Santilli, MBA
November 2019 Vol 12, No 7 in Industry Trends
Employer-Sponsored Wellness Programs for Hypertension and Dyslipidemia in a 2-Hospital Health System
Anne Misher, PharmD, BCACP, BC-ADM, CDE, F. Randy Vogenberg, PhD, FASHP, Jessica Brown, PharmD, Christina Maguire, PharmD, Alix P. Schnibben, PharmD, BCACP, CTTS
October 2019 Vol 12, No 6 in Clinical, Original Research
US Healthcare Trends and Contradictions in 2019
F. Randy Vogenberg, PhD, FASHP
February 2019 Vol 12, No 1 in Industry Trends
Patient Preferences Associated with Therapies for Psoriatic Arthritis: A Conjoint Analysis
Yihua Xu, PhD, F. Randy Vogenberg, PhD, FASHP, Lavanya Sudharshan, MS, Ming-Ann Hsu, MPH, Andrew S. Koenig, DO, FACR, Joseph C. Cappelleri, PhD, Wen F. Liu, PharmD, BCPS, Timothy W. Smith, BA, Margaret K. Pasquale, PhD
November 2018 Vol 11, No 8 in Clinical, Original Research
Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia
F. Randy Vogenberg, PhD, FASHP, Craig White, PhD, Winghan Jacqueline Kwong, PharmD, PhD, Hilary Armstrong, PhD, Michael Behling, Jeffrey Niemira, Kathy Lang, PhD
September 2018 Vol 11, No 6 in Clinical, Original Research
Healthcare Trends for 2018
F. Randy Vogenberg, PhD, FASHP, John Santilli, MBA
February 2018 Vol 11, No 1 in Industry Trends
The Value of Pre–FDA Approval Healthcare Economic Information Exchange Between Payers and Drug Manufacturers
Peter R. Fendt, PharmD, MBA, Brian Ung, PharmD, RPh, F. Randy Vogenberg, PhD, FASHP
November 2017 Vol 10, No 8 in Industry Trends
Economic Impact of Increased Utilization of Multivariate Assay Testing to Guide the Treatment of Ovarian Cancer: Implications for Payers
Burton S. Brodsky, MD, F. Randy Vogenberg, PhD, FASHP, Gary M. Owens, MD, Dennis J. Scotti, PhD, MBA, Keith A. Needham, BS, Christina L. Cool, MPH
October 2017 Vol 10, No 7 in Business, Original Research
Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis
Kumar Mukherjee, PhD, F. Randy Vogenberg, PhD, FASHP, Khalid M. Kamal, PhD
February 2017 Vol 10, No 1 in Business
Top 10 Healthcare Market Trends in 2017
John Santilli, MBA, F. Randy Vogenberg, PhD, FASHP
February 2017 Vol 10, No 1 in Industry Trends
Employer Perspectives on a Specialty Drug Step-Therapy Program Evaluation
Matthew Harman, PharmD, MPH, F. Randy Vogenberg, PhD, FASHP
September 2016 Vol 9, No 6 in Industry Trends
Hospital and Health Plan Partnerships: The Affordable Care Act’s Impact on Promoting Health and Wellness
Michelle Vu, PharmD candidate, F. Randy Vogenberg, PhD, FASHP, Annesha White, PharmD, PhD, Virginia P. Kelley, MBA, Jennifer Kuca Hopper, MS, Cathy Liu, PharmD candidate
July 2016 Vol 9, No 5 in Business
Top Healthcare Market Trends in 2016
John Santilli, MBA, F. Randy Vogenberg, PhD, FASHP
February 2016 Vol 9, No 1 in Industry Trends
Employers Engaged in Benefit Design Innovation: Long-Term Trends in a 2015 National Survey
Cheryl Larson, F. Randy Vogenberg, PhD, FASHP
December 2015 Vol 8, No 9 in Perspectives
Optimizing Rheumatoid Arthritis Therapy: Using Objective Measures of Disease Activity to Guide Treatment
Gary M. Owens, MD, F. Randy Vogenberg, PhD, FASHP
October 2015 Vol 8, No 7 in Clinical
Guiding Employer Management of Specialty Drugs
Cheryl Larson, F. Randy Vogenberg, PhD, FASHP
July/August 2015 Vol 8 No 5 in Perspectives
The Cost of Unintended Pregnancies for Employer-Sponsored Health Insurance Plans
Gabriela Dieguez, FSA, MAAA, F. Randy Vogenberg, PhD, FASHP, Amy W. Law, PharmD, Richard Lynen, MD, James Trussell, PhD, Bruce S. Pyenson, FSA, MAAA
April 2015, Vol 8, No 2 in Business
Key Strategic Trends that Impact Healthcare Decision-Making and Stakeholder Roles in the New Marketplace
John Santilli, MBA, F. Randy Vogenberg, PhD, FASHP
February 2015 Vol 8, No 1 in Perspectives
Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend
Christopher M. Blanchette, PhD, MBA, Nicholas J. Gross, MD, PhD, Pablo Altman, MD, MBA, F. Randy Vogenberg, PhD, FASHP
April 2014 Vol 7, No 2 in Business
The Incidence Rate and Economic Burden of Community-Acquired Pneumonia in a Working-Age Population
Jonah Broulette, ASA, MAAA, F. Randy Vogenberg, PhD, FASHP, Holly Yu, MSPH, Kosuke Iwasaki, FIAJ, MAAA, Reiko Sato, PhD, Bruce S. Pyenson, FSA, MAAA
September/October 2013, Vol 6, No 8 in Business
Addressing Adherence Issues
F. Randy Vogenberg, PhD, FASHP
Videos
Affordability of Cancer as a Chronic Disease
F. Randy Vogenberg, PhD, FASHP
Videos
Developing an Accurate Price Model for Personalized Medicines
F. Randy Vogenberg, PhD, FASHP
Videos
Incorporating ACOs in Oncology
F. Randy Vogenberg, PhD, FASHP
Videos
Implications of the Employer Mandate Delay on the Healthcare Marketplace
Kip Piper, MA, FACHE, F. Randy Vogenberg, PhD, FASHP
July/August 2013 Vol 6, No 6 in Perspectives
Beyond the Cost of Biologics: Employer Survey Reveals Gap in Understanding Role of Specialty Pharmacy and Benefit Design
F. Randy Vogenberg, PhD, FASHP, Atheer A. Kaddis, PharmD, Cheryl Larson, Margaret Rehayem, MA, Larry Boress, MPA
January/February 2012, Vol 5, No 1 in Business
Are ACOs the Answer to High-Value Healthcare?
Wing Yeung, MA, F. Randy Vogenberg, PhD, FASHP, Harrison Burns, III, BS, PAHM, Deryk Loiacono, PharmD
November/December 2011, Vol4, No7 in Regulatory
Adapting to Market Changes: Beyond Healthcare Reform
F. Randy Vogenberg, PhD, FASHP
September/October 2011 Volume 4, Number 6 in Perspectives
Engaging Providers in Medication Adherence: A Health Plan Case Study
Amy B. Scott, BSPharm, RPh, Jane E. McClure, BA, RN, F. Randy Vogenberg, PhD, FASHP
November/December 2010, Vol 3, No 6 in Clinical, Original Research
A Wellness-Based Healthcare System for Chronic Diseases: Prevention, Intervention, and Innovation
Robert E. Henry, Kip Piper, MA, FACHE, F. Randy Vogenberg, PhD, FASHP, Thomas McCarter, MD, FACP, Farrah N. Daly, MD, MBA, Keri Cooper, Nirav R. Shah, MD,MPH, Lawton Robert Burns, PhD, MBA, Gene Reeder, RPh, PhD, Scott Gottlieb, MD, Toni Fera, BPharm, PharmD, Wayne M. Lednar, MD, PhD, Alberto M. Colombi, MD, MPH, Michael F. Murphy, MD, PhD, Gary M. Owens, MD, James T. Kenney, RPh, MBA, J. B. Jones, PhD, MBA, Walter F. Stewart, PhD, MPH
Supplements
FDA WATCH
Wayne Kuznar, Nirav R. Shah, MD,MPH, F. Randy Vogenberg, PhD, FASHP
February/March 2009, Vol 2, No 2 in FDA Approvals, Perspectives
Benchmarking New Frontiers in Managed Care Pharmacy
Cynthia Pigg, BSPharm, MHA , F. Randy Vogenberg, PhD, FASHP, Joan Cihak, MSS, MHA
April 2008, Vol 1, No 3 in Business
Not Waiting for Godot: The Evolution of Health Promotion at PPG Industries
Alberto M. Colombi, MD, MPH, F. Randy Vogenberg, PhD, FASHP, Janice L. Pringle, PhD, George T. Welsh, BS, MBA
April 2008, Vol 1, No 3 in Business
Trends in Pharmaceutical Expenditures: The Impact on Drug Benefit Design
Joanne LaFleur, PharmD, MSPH, F. Randy Vogenberg, PhD, FASHP, Leslie Fish, PharmD
May 2008, Vol 1, No 4 in Business
Disruptive Innovation: Value-Based Health Plans
F. Randy Vogenberg, PhD, FASHP, Kip Piper, MA, FACHE
February 2008, Vol 1, No 1 in Business
Delaware's Wellness Program: Motivating Employees Improves Health and Saves Money
Jennifer "J.J" Davis, F. Randy Vogenberg, PhD, FASHP
September 2008, Vol 1, No 7 in Business
Erythropoiesis-Stimulating Agents in a Meta-Stable State: Guidelines, Economics, and Policy in Flux
F. Randy Vogenberg, PhD, FASHP
November/December 2008, Vol 1, No 9 in Regulatory
Applying Evidence for Medical Technologies: Closing the Gap between R&D and Decision Maker Needs
F. Randy Vogenberg, PhD, FASHP
June/July 2009, Vol 2, No 4 in Regulatory
Biosimilars Policy Forum: Perspectives on Safety and Efficacy of Future Products
F. Randy Vogenberg, PhD, FASHP
June/July 2009, Vol 2, No 4 in Industry Trends
Health Insurance Premium Increases for the 5 Largest School Districts in the United States, 2004-2008
John R. Cantillo, MBA, F. Randy Vogenberg, PhD, FASHP
March/April 2010, Vol 3, No 2 in Business
Predictive and Prognostic Models: Implications for Healthcare Decision-Making in a Modern Recession
F. Randy Vogenberg, PhD, FASHP, Jason Roy, PhD
September/October 2009, Vol 2, No 6 in Regulatory
Health Benefit Coverage, Reimbursement, and Influences on Traditional Pharmaceutical Channels
F. Randy Vogenberg, PhD, FASHP, Gary M. Owens, MD
May/June 2010, Vol 3, No 3 in Business
Last modified: December 21, 2022
SUBSCRIBE
© Amplity Health. All rights reserved.